Argan Oil

1. INCI et CAS

INCI: Argan Oil · CAS: en attente de confirmation du fournisseur ou de la réglementation pour le grade sélectionné

2. Rôle dans la formule

Argan Oil is carried as a named cosmetic ingredient for this SKU. Identity, assay and impurities are confirmed on the supplier TDS and COA. This page does not invent a CAS or a drug effect.

3. Niveaux d'emploi typiques (repère de formulation)

• Follow the supplier TDS for the finished formula's use range.

Use the supplier TDS for solvent, temperature and pH.

4. Sources réglementaires et conformité mondiale

• A CosIng entry naming Argan Oil does not by itself approve the purchased grade or complete cosmetic.
• Before EU placement, Regulation (EC) No 1223/2009 requires the completed product containing Argan Oil to receive its own safety assessment for the completed formula, not simply for an ingredient in isolation.
• Check the supplier's technical information for the Argan Oil grade and confirm the relevant market filing list.

5. Sécurité et évaluation des risques

The percentage is shown for cosmetic development; it is not evidence of drug approval or OTC authorization with patch and stability testing still needed for the completed formula.

6. Stabilité et conditionnement

Keep the ingredient in cool, closed bulk storage away from sunlight; evaluate packaging against the formula's susceptibility to oxidation; then verify formula stability and pack compatibility on the confirmed batch.

7. Formulations d'allégations (à faire / à éviter)

• Names Argan Oil as a cosmetic ingredient on this SKU

• This ingredient reference does not support a drug effect, a clinical cure, or certification status not established for the SKU.
• The formulation record for Argan Oil should not be used to substantiate whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.

1. INCI et CAS

INCI: Caprylic/Capric Triglyceride · CAS: 73398-61-5

2. Rôle dans la formule

For light-oil use in lotions, balms, and cleansing oils, the reference lists caprylic/capric triglyceride.

3. Niveaux d'emploi typiques (repère de formulation)

• For lotions, the reference gives 3–8%.
• For cleansing oils and balms, use 20–60% in this reference.

Route Caprylic/Capric Triglyceride through the oil phase.

4. Sources réglementaires et conformité mondiale

• The CosIng record for Caprylic/Capric Triglyceride, where listed, is informational rather than product-specific authorization.
• An EU-market cosmetic under Regulation (EC) No 1223/2009 requires an assessment of the safety of the final cosmetic containing Caprylic/Capric Triglyceride for the completed formula, not simply for an ingredient in isolation.
• Review the supplier TDS for the received Caprylic/Capric Triglyceride grade, together with the target market's current filing requirements.

5. Sécurité et évaluation des risques

This formulation note gives a cosmetic-use reference level; no drug approval or OTC-monograph status follows from this guide so assess patch response and stability in the final formula.

6. Stabilité et conditionnement

Store sealed bulk away from heat and sunlight; where oxidation is a concern, evaluate airless or pump packaging; then verify formula stability and pack compatibility on the confirmed batch.

7. Formulations d'allégations (à faire / à éviter)

• The recorded cosmetic positioning for Caprylic/Capric Triglyceride highlights light-triglyceride.

• This cosmetic guide does not support claims of drug action or cure, or a product certification outside the supporting records.
• The formulation record for Caprylic/Capric Triglyceride does not support skin whitening, acne treatment, antiperspirant use, sun protection, or hair growth.

1. INCI et CAS

INCI: Squalane · CAS: 111-01-3

2. Rôle dans la formule

This reference identifies squalane as a stable hydrocarbon emollient and calls for a plant-derived grade, not mineral oil.

3. Niveaux d'emploi typiques (repère de formulation)

• For gel-creams, use 2–6% in this reference.
• The stated reference for dry oils is 10–30% in this reference.
• For balms, the recorded level is 5–15%.

The oil phase is the addition point for Squalane, with no high-shear wax operation.

4. Sources réglementaires et conformité mondiale

• Use CosIng's information on Squalane as a reference, then verify the specific grade and intended use under market rules.
• Regulation (EC) No 1223/2009 sets the requirement for a safety assessment of the finished cosmetic containing Squalane rather than for an ingredient name alone.
• Confirm the received Squalane grade against supplier documentation, then verify the intended market's filing requirements.

5. Sécurité et évaluation des risques

The stated concentration is a cosmetic-development reference; this reference is not approval for drug use or OTC marketing and the finished formula still needs patch and stability testing.

6. Stabilité et conditionnement

Protect sealed bulk from warmth and direct light; where appropriate, assess an airless or pump pack for oxidation-sensitive systems; follow with stability and packaging checks on the confirmed batch.

7. Formulations d'allégations (à faire / à éviter)

• This guide frames Squalane's cosmetic direction around a light-emollient role.

• The ingredient guidance does not substantiate drug effects, clinical cures, or unsupported product certifications.
• This guide to Squalane provides no basis for whitening effects, acne treatment, antiperspirant performance, sunscreen protection, or hair growth.